API Red List

Analysis

13 NOV 2026 Sandoz Settles for $469M. Teva Faces a Price-Fixing Trial in February Case Files
12 NOV 2026 Cytarabine Shortage: A ₹330 Crore Pfizer JV Plant Is Out Until 2028 Signals
06 NOV 2026 Palbociclib Drops 93% to ₹2,720. Roche’s ₹123,506 Vial Doesn’t Budge Opinion
03 NOV 2026 Baxter Warning Letter Ends a $50M Cephalosporin Line With 60% Margins Case Files
30 OCT 2026 Sugammadex Generics Wipe $353M Off Merck’s Bridion in One Quarter Market Watch
28 SEP 2026 The $245 Discount: Medicare Pays Up to 17× India’s Price for the Same Weight-Loss Molecule – and Calls It a Bargain Opinion, Signals
21 SEP 2026 The Annex III Club: Why September 29 Is the Real Deadline in Pharma’s Tariff War Regulatory
17 APR 2026 Antibiotic OPEC: The Shadow Cartels Monetizing the Ruins of the Strait of Hormuz Market Watch, Opinion
04 MAR 2026 The 21% Correction: Why Public Markets Are No Longer Buying Biotech Platforms Without Clinical Anchors Market Watch, Signals
20 FEB 2026 Stop Searching, Start Connecting: Your Global API & FDF Hub Market Watch
11 DEC 2025 Checkbook Darwinism: Why Merck and Roche Are Paying ‘Panic Premiums’ to Avert Extinction Market Watch, Signals
14 OCT 2025 Regulatory Shock Trades: How FDA Letters Move Billions Before Lunch Market Watch, Signals
10 OCT 2025 Data Integrity’s New Price Tag: How Compliance Failures Now Move Stock Prices in Hours Case Files, Signals
20 SEP 2025 Regulatory Pressure & Supply Shock: Why Europe’s Drug Shortages Became Chronic – and What Everyone’s Missing Deep Dives, Regulatory
10 SEP 2025 Nitrosamines 2.0: new AI thresholds, new “casualties,” and finally predictable rules Signals
23 AUG 2025 Cracking Down on Orphan Drug Abuse: The ORPHAN Cures Act and Its Impact Opinion, Deep Dives
23 AUG 2025 Britain’s Big Pharma Showdown: NHS Drug Levy Sparks £11 Billion R&D Exodus Threat Market Watch, Opinion
23 AUG 2025 Dirty Pills and Empty Shelves: How Outsourcing Broke America’s Drug Supply Supply Chain, Market Watch
23 AUG 2025 When Trust Fails in Pharma: How Data Corruption in API Manufacturing Will Trigger a Billion-Dollar Investor Exodus in 2025–2026 Case Files, Exposés
22 AUG 2025 Paper Cuts: Dossier Mistakes That Stopped Big Drugs Cold Case Files, Regulatory